HWAM
Hennion & Walsh Asset Management’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.96M | Sell |
26,709
-1,559
| -6% | -$289K | 0.2% | 116 |
|
|
2025
Q1 | $5.92M | Sell |
28,268
-4,538
| -14% | -$951K | 0.26% | 74 |
|
|
2024
Q4 | $5.83M | Sell |
32,806
-45
| -0.1% | -$8K | 0.26% | 79 |
|
|
2024
Q3 | $6.48M | Buy |
32,851
+4,688
| +17% | +$925K | 0.3% | 62 |
|
|
2024
Q2 | $4.83M | Sell |
28,163
-273
| -1% | -$46.8K | 0.25% | 91 |
|
|
2024
Q1 | $5.18M | Sell |
28,436
-3,848
| -12% | -$701K | 0.28% | 76 |
|
|
2023
Q4 | $5M | Sell |
32,284
-4,849
| -13% | -$751K | 0.29% | 73 |
|
|
2023
Q3 | $5.54M | Sell |
37,133
-6,236
| -14% | -$930K | 0.35% | 50 |
|
|
2023
Q2 | $5.84M | Buy |
43,369
+3,527
| +9% | +$475K | 0.35% | 61 |
|
|
2023
Q1 | $6.35M | Buy |
39,842
+62
| +0.2% | +$9.88K | 0.39% | 58 |
|
|
2022
Q4 | $6.43M | Buy |
39,780
+6,151
| +18% | +$994K | 0.4% | 58 |
|
|
2022
Q3 | $4.51M | Buy |
33,629
+16
| +0% | +$2.15K | 0.3% | 80 |
|
|
2022
Q2 | $5.15M | Buy |
33,613
+7,099
| +27% | +$1.09M | 0.32% | 75 |
|
|
2022
Q1 | $4.3M | Sell |
26,514
-838
| -3% | -$136K | 0.23% | 118 |
|
|
2021
Q4 | $3.7M | Sell |
27,352
-1,643
| -6% | -$222K | 0.18% | 151 |
|
|
2021
Q3 | $3.13M | Buy |
28,995
+257
| +0.9% | +$27.7K | 0.16% | 182 |
|
|
2021
Q2 | $3.24M | Buy |
28,738
+1,720
| +6% | +$194K | 0.17% | 171 |
|
|
2021
Q1 | $2.92M | Buy |
+27,018
| New | +$2.92M | 0.18% | 166 |
|